relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa to Present at Two Upcoming Conferences
September 02, 2015 08:30 ET | Relypsa, Inc.
REDWOOD CITY, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP) today announced that the company will present at two upcoming investor conferences in September 2015. Kristine...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa Announces New Employment Inducement Grants
August 18, 2015 16:30 ET | Relypsa, Inc.
REDWOOD CITY, Calif., Aug. 18, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on August 17, 2015, the compensation committee of the company's...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa Enters Two-Year Detailing Agreement With Sanofi in the United States
August 10, 2015 16:06 ET | Relypsa, Inc.
REDWOOD CITY, Calif., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Relypsa Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced it has entered a two-year detailing agreement with Sanofi for Patiromer...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa and Vifor Fresenius Medical Care Renal Pharma Enter Into Partnership to Commercialize Patiromer FOS in Europe and Additional Territories
August 10, 2015 16:05 ET | Relypsa, Inc.
REDWOOD CITY, Calif., and ST. GALLEN, Switzerland, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, and Vifor Fresenius Medical Care Renal Pharma Ltd....
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa Announces Second Quarter 2015 Financial Results
August 06, 2015 16:15 ET | Relypsa, Inc.
REDWOOD CITY, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today reported financial results for the quarter ended June 30, 2015. Net loss for the...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa Announces New Employment Inducement Grants
August 05, 2015 08:30 ET | Relypsa, Inc.
REDWOOD CITY, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on August 3, 2015, the compensation committee of the company's...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa to Present at the 2015 Wedbush PacGrow Healthcare Conference
August 03, 2015 08:30 ET | Relypsa, Inc.
REDWOOD CITY, Calif., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), today announced that John A. Orwin, president and chief executive officer, will present at the 2015 Wedbush PacGrow...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa Announces New Employment Inducement Grants
July 24, 2015 08:30 ET | Relypsa, Inc.
REDWOOD CITY, Calif., July 24, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on July 15, 2015, the compensation committee of the company's...
relypsa_viforgroup_logo_medium_color (1).jpg
JAMA Publishes Long-Term Safety and Efficacy Results of Trial With Relypsa's Patiromer FOS Over One Year
July 14, 2015 11:48 ET | Relypsa, Inc.
Patiromer FOS significantly decreased blood potassium levels in patients with chronic kidney disease and hyperkalemia at four weeks (primary endpoint) Potassium levels were maintained at...
relypsa_viforgroup_logo_medium_color (1).jpg
Relypsa Announces New Employment Inducement Grants
July 02, 2015 08:30 ET | Relypsa, Inc.
REDWOOD CITY, Calif., July 2, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on July 1, 2015, the compensation committee of the company's board...